207 related articles for article (PubMed ID: 35183358)
21. Early detection and prevention of pancreatic cancer: is it really possible today?
Del Chiaro M; Segersvärd R; Lohr M; Verbeke C
World J Gastroenterol; 2014 Sep; 20(34):12118-31. PubMed ID: 25232247
[TBL] [Abstract][Full Text] [Related]
22. Moderators of cancer-related distress and worry after a pancreatic cancer genetic counseling and screening intervention.
Hart SL; Torbit LA; Crangle CJ; Esplen MJ; Holter S; Semotiuk K; Borgida A; Ardiles P; Rothenmund H; Gallinger S
Psychooncology; 2012 Dec; 21(12):1324-30. PubMed ID: 21774034
[TBL] [Abstract][Full Text] [Related]
23. Pancreatic cancer risk counselling and screening: impact on perceived risk and psychological functioning.
Maheu C; Vodermaier A; Rothenmund H; Gallinger S; Ardiles P; Semotiuk K; Holter S; Thayalan S; Esplen MJ
Fam Cancer; 2010 Dec; 9(4):617-24. PubMed ID: 20623197
[TBL] [Abstract][Full Text] [Related]
24. Hereditary Pancreatic Cancer Syndromes: Providing Care to At-Risk Families.
King E; Nehoray BM
Clin J Oncol Nurs; 2019 Dec; 23(6):579-582. PubMed ID: 31730603
[TBL] [Abstract][Full Text] [Related]
25. Current Approaches to Pancreatic Cancer Screening.
Chhoda A; Lu L; Clerkin BM; Risch H; Farrell JJ
Am J Pathol; 2019 Jan; 189(1):22-35. PubMed ID: 30558719
[TBL] [Abstract][Full Text] [Related]
26. Risk factors for pancreatic adenocarcinoma: are we ready for screening and surveillance?
Brand R; Mahr C
Curr Gastroenterol Rep; 2005 May; 7(2):122-7. PubMed ID: 15802100
[TBL] [Abstract][Full Text] [Related]
27. Validation of Biomarkers for Early Detection of Pancreatic Cancer: Summary of The Alliance of Pancreatic Cancer Consortia for Biomarkers for Early Detection Workshop.
Young MR; Wagner PD; Ghosh S; Rinaudo JA; Baker SG; Zaret KS; Goggins M; Srivastava S
Pancreas; 2018 Feb; 47(2):135-141. PubMed ID: 29346214
[TBL] [Abstract][Full Text] [Related]
28. [Risk factors and early diagnosis of pancreatic cancer].
López Serrano A
Gastroenterol Hepatol; 2010 May; 33(5):382-90. PubMed ID: 20005016
[TBL] [Abstract][Full Text] [Related]
29. Deleterious Germline Mutations Are a Risk Factor for Neoplastic Progression Among High-Risk Individuals Undergoing Pancreatic Surveillance.
Abe T; Blackford AL; Tamura K; Ford M; McCormick P; Chuidian M; Almario JA; Borges M; Lennon AM; Shin EJ; Klein AP; Hruban RH; Canto MI; Goggins M
J Clin Oncol; 2019 May; 37(13):1070-1080. PubMed ID: 30883245
[TBL] [Abstract][Full Text] [Related]
30. Familial pancreatic cancer: a review and latest advances.
Grocock CJ; Vitone LJ; Harcus MJ; Neoptolemos JP; Raraty MG; Greenhalf W
Adv Med Sci; 2007; 52():37-49. PubMed ID: 18217388
[TBL] [Abstract][Full Text] [Related]
31. Pancreatic Tumorigenesis: Precursors, Genetic Risk Factors and Screening.
Badheeb M; Abdelrahim A; Esmail A; Umoru G; Abboud K; Al-Najjar E; Rasheed G; Alkhulaifawi M; Abudayyeh A; Abdelrahim M
Curr Oncol; 2022 Nov; 29(11):8693-8719. PubMed ID: 36421339
[TBL] [Abstract][Full Text] [Related]
32. Short-term Results of a Magnetic Resonance Imaging-Based Swedish Screening Program for Individuals at Risk for Pancreatic Cancer.
Del Chiaro M; Verbeke CS; Kartalis N; Pozzi Mucelli R; Gustafsson P; Hansson J; Haas SL; Segersvärd R; Andren-Sandberg Å; Löhr JM
JAMA Surg; 2015 Jun; 150(6):512-8. PubMed ID: 25853369
[TBL] [Abstract][Full Text] [Related]
33. Pancreatic ductal adenocarcinoma: risk factors, screening, and early detection.
Becker AE; Hernandez YG; Frucht H; Lucas AL
World J Gastroenterol; 2014 Aug; 20(32):11182-98. PubMed ID: 25170203
[TBL] [Abstract][Full Text] [Related]
34. Pancreatic cancer: epidemiology, genetics, and approaches to screening.
Konner J; O'Reilly E
Oncology (Williston Park); 2002 Dec; 16(12):1615-22, 1631-2; discussion 1632-3, 1637-8. PubMed ID: 12520639
[TBL] [Abstract][Full Text] [Related]
35. Comment on: 'Development of PancRISK, a urine biomarker-based risk score for stratified screening of pancreatic cancer patients'.
De Marco M; Rosati A; Turco MC; Marzullo L
Br J Cancer; 2020 Oct; 123(9):1467. PubMed ID: 32741973
[No Abstract] [Full Text] [Related]
36. International Cancer of the Pancreas Screening (CAPS) Consortium summit on the management of patients with increased risk for familial pancreatic cancer.
Canto MI; Harinck F; Hruban RH; Offerhaus GJ; Poley JW; Kamel I; Nio Y; Schulick RS; Bassi C; Kluijt I; Levy MJ; Chak A; Fockens P; Goggins M; Bruno M;
Gut; 2013 Mar; 62(3):339-47. PubMed ID: 23135763
[TBL] [Abstract][Full Text] [Related]
37. Five years of prospective screening of high-risk individuals from families with familial pancreatic cancer.
Langer P; Kann PH; Fendrich V; Habbe N; Schneider M; Sina M; Slater EP; Heverhagen JT; Gress TM; Rothmund M; Bartsch DK
Gut; 2009 Oct; 58(10):1410-8. PubMed ID: 19470496
[TBL] [Abstract][Full Text] [Related]
38. Pancreatic cancer screening: identifying premalignant disease.
James TA; Gibbs JF
Future Oncol; 2005 Apr; 1(2):191-5. PubMed ID: 16555989
[TBL] [Abstract][Full Text] [Related]
39. Screening for pancreatic cancer in high-risk individuals: a call for endoscopic ultrasound.
Larghi A; Verna EC; Lecca PG; Costamagna G
Clin Cancer Res; 2009 Mar; 15(6):1907-14. PubMed ID: 19276278
[TBL] [Abstract][Full Text] [Related]
40. Early detection of pancreatic cancer: Where are we now and where are we going?
Zhou B; Xu JW; Cheng YG; Gao JY; Hu SY; Wang L; Zhan HX
Int J Cancer; 2017 Jul; 141(2):231-241. PubMed ID: 28240774
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
